FR2334350B2 - - Google Patents

Info

Publication number
FR2334350B2
FR2334350B2 FR7637514A FR7637514A FR2334350B2 FR 2334350 B2 FR2334350 B2 FR 2334350B2 FR 7637514 A FR7637514 A FR 7637514A FR 7637514 A FR7637514 A FR 7637514A FR 2334350 B2 FR2334350 B2 FR 2334350B2
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7637514A
Other languages
French (fr)
Other versions
FR2334350A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19752555685 external-priority patent/DE2555685A1/de
Priority claimed from DE19752557003 external-priority patent/DE2557003A1/de
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of FR2334350A2 publication Critical patent/FR2334350A2/fr
Application granted granted Critical
Publication of FR2334350B2 publication Critical patent/FR2334350B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/66Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR7637514A 1975-12-11 1976-12-13 Nouveaux derives d'anilides de l'acide cyanoacetique, leur procede de preparation et leur application Granted FR2334350A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19752555685 DE2555685A1 (de) 1975-12-11 1975-12-11 Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel
DE19752557003 DE2557003A1 (de) 1975-12-18 1975-12-18 Neue cyanessigsaeureanilid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel

Publications (2)

Publication Number Publication Date
FR2334350A2 FR2334350A2 (fr) 1977-07-08
FR2334350B2 true FR2334350B2 (de) 1980-03-07

Family

ID=25769723

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7637514A Granted FR2334350A2 (fr) 1975-12-11 1976-12-13 Nouveaux derives d'anilides de l'acide cyanoacetique, leur procede de preparation et leur application

Country Status (12)

Country Link
JP (1) JPS5273830A (de)
CA (1) CA1092133A (de)
CH (6) CH632487A5 (de)
DK (1) DK545976A (de)
ES (6) ES453963A2 (de)
FR (1) FR2334350A2 (de)
GB (1) GB1571990A (de)
IE (1) IE44047B1 (de)
IT (1) IT1124789B (de)
LU (1) LU76354A1 (de)
MX (1) MX4758E (de)
NL (1) NL7613547A (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3361451D1 (en) * 1982-03-05 1986-01-23 Fbc Ltd Fungicidal cyanopropenoates and compositions containing them
DE3534440A1 (de) * 1985-09-27 1987-04-02 Hoechst Ag Arzneimittel gegen chronische graft-versus-host-krankheiten sowie gegen autoimmunerkrankungen, insbesondere systemischen lupus erythematodes
GB8619433D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
US6355678B1 (en) * 1998-06-29 2002-03-12 Parker Hughes Institute Inhibitors of the EGF-receptor tyrosine kinase and methods for their use
EP2303835A1 (de) 2008-07-29 2011-04-06 Alembic Limited Verfahren zur herstellung von teriflunomid

Also Published As

Publication number Publication date
CH630342A5 (en) 1982-06-15
CH632487A5 (en) 1982-10-15
NL7613547A (nl) 1977-06-14
JPS5273830A (en) 1977-06-21
ES475111A1 (es) 1979-05-01
CA1092133A (en) 1980-12-23
MX4758E (es) 1982-09-03
ES475108A2 (es) 1979-08-01
IE44047B1 (en) 1981-07-29
ES453963A2 (es) 1978-05-01
ES466542A2 (es) 1979-01-16
ES475109A1 (es) 1979-04-16
CH629756A5 (en) 1982-05-14
FR2334350A2 (fr) 1977-07-08
ES475110A1 (es) 1979-05-01
GB1571990A (en) 1980-07-23
CH630341A5 (en) 1982-06-15
LU76354A1 (de) 1977-06-24
IT1124789B (it) 1986-05-14
IE44047L (en) 1977-06-11
CH629755A5 (en) 1982-05-14
CH629757A5 (en) 1982-05-14
DK545976A (da) 1977-06-12

Similar Documents

Publication Publication Date Title
FR2334350B2 (de)
AU496168B2 (de)
CH599544A5 (de)
BG22434A1 (de)
BE846112A (de)
BG21073A1 (de)
BG21641A1 (de)
CH599590B5 (de)
BG22639A1 (de)
BG22694A1 (de)
BG22913A1 (de)
BG23519A1 (de)
CH599748A5 (de)
CH585634A5 (de)
CH586541A5 (de)
CH586768A5 (de)
CH588663A5 (de)
CH591438A5 (de)
CH591866A5 (de)
CH592890A5 (de)
CH593493A5 (de)
CH594132A5 (de)
CH594311A5 (de)
CH595421A5 (de)
CH595562A5 (de)